Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Myria Biosciences is revolutionizing drug discovery by integrating synthetic biology, artificial intelligence, and super-speed analytics to create AI-designed microbes that produce novel therapeutic…

Myria Biosciences is revolutionizing drug discovery by integrating synthetic biology, artificial intelligence, and super-speed analytics to create AI-designed microbes that produce novel therapeutic…
What they do: Use synthetic biology + AI (GEMMS platform) to design microbes that produce novel therapeutic compounds
HQ: Basel, Switzerland
Founded: 2022
Stage / funding: Pre-seed (closed June 2024) with named investors including Creator Fund
Team size: About 10 employees (reported)
Drug discovery for unmet medical needs; accessing novel chemical space using engineered biology
2022
Biotechnology
Pre-seed round announced as closed on company site (20 June 2024); investor participants include Creator Fund (lead), Capital Blue Partners, Rockmount Seed Investments.
“Led by Creator Fund with participation from Capital Blue Partners and Rockmount Seed Investments”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
400+
New This Week